Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Wegovy lawsuit claims center on allegations that Novo Nordisk failed to adequately warn patients and prescribing physicians about serious risks linked to semaglutide
Important safety information Certain GLP-1 therapies such as semaglutide (the active ingredient in Ozempic, Rybelsus, and Wegovy), liraglutide (the active ingredient in Saxenda and Victoza), and tirzepatide (the active ingredient in Mounjaro and Zepbound) may increase the likelihood of developing thyroid gland tumors, including MTC, a type of thyroid cancer
doi: 10.1007/s00125-018-4729-5 17 American Diabetes Association Professional Practice CommitteeDrazninBArodaVRBakrisGBensonGBrownFMet al
How to Verify the Pharmacy and Prescriber Before starting any telehealth-prescribed medication, consider taking these verification steps: Verify prescriber licensure: Check your state medical board's website to confirm the prescribing provider holds an active, valid license in your state
For injectable GLP-1 medications, timing relative to levothyroxine is less critical since the interaction occurs through general effects on gastric emptying rather than direct simultaneous absorption
US$ 29.73
US$ 20.05
US$ 20.05
US$ 28.30
US$ 20.09
US$ 23.51
US$ 22.28
